Real-World Outcomes of Combination Anthracycline and Taxane Adjuvant Therapies in Early Triple-Negative Breast Cancer: A Moroccan Retrospective Analysis
PURPOSENeoadjuvant chemoimmunotherapy followed by adjuvant immunotherapy is the gold standard for treating patients with higher risk early triple-negative breast cancer (TNBC); however, in some cases, these patients undergo surgery followed by chemotherapy-based anthracyclines and taxanes without ad...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
American Society of Clinical Oncology
2025-05-01
|
| Colección: | JCO Global Oncology |
| Acceso en línea: | https://ascopubs.org/doi/10.1200/GO-24-00650 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|